Wed 28 Oct 2026 00:50:42 BST
Search Company
*

Active Substance
New Active Substance
Search Site
--
*

Create Site
--
*
*
*
*
*
*
Update Site
Current data stored in EudraGMDP databaseCurrent data stored in OMS
--
Characters remaining:4000/4000
New Active Substance Importation
Active Substance*
Active Substance (English):
Active Substance (NL):
NCA Reference Key:
3rd Country Manufacturer
3rd Country ManufacturerOMS Location IdentifierOMS Organisation IdentifierLegal AddressNCA Reference KeyConfidentialEditDelete
No records found.

3rd Country Distributor
3rd Country DistributorOMS Location IdentifierOMS Organisation IdentifierLegal AddressNCA Reference KeyConfidentialEditDelete
No records found.

RTF Template


National Center For Public Health And Pharmacy

UNION FORMAT FOR A WHOLESALE DISTRIBUTION AUTHORISATION

Human medicinal products


1. Authorisation Number

:

HU-D-QPHA

2. Name of Authorisation Holder

:

Q Pharma Kft.

(ORG-100003381 / LOC-100028039)

3. Address(es) of Site(s)

:

Naplas Ut 24, Nagytarcsa, 2142, Hungary 




4. Legally registered address of Authorisation Holder

:

Naplas Ut 24, Nagytarcsa, 2142

5. Scope of authorisation (complete for each site under 4)

:

ANNEX 1

6. Legal basis of authorisation

:

Art. 77(1) of Directive 2001/83/EC

7. Name of responsible officer of the competent authority of the member state granting the wholesaling authorisation

:

Confidential, Confidential

8. Signature

:


9. Date

:

2023-10-09

10. Annexes attached

:

Annex 1 Scope of wholesale distribution authorisation

Annex 2 (Optional) Address(es) of contract wholesale distribution sites and their authorisation number

Annex 3 (Optional) Name(s) of responsible person(s)

Annex 4 (Optional) Date of Inspection on which authorisation was granted

Annex 5 (Optional) Additional provisions based on national requirements


ANNEX 1

SCOPE OF WHOLESALE DISTRIBUTION AUTHORISATION



Name and address of the site: Q Pharma Kft.

(ORG-100003381 / LOC-100028039)

, Naplas Ut 24, Nagytarcsa, 2142, Hungary   



Human medicinal products


1. MEDICINAL PRODUCTS

   1.1. with a Marketing Authorisation in EEA country(s)

   1.2. without a Marketing Authorisation in the EEA and intended for EEA market

   1.3. without a Marketing Authorisation in the EEA and intended for exportation


2. AUTHORISED WHOLESALE DISTRIBUTION OPERATIONS

   2.1. Procurement 

   2.2. Holding 

   2.3. Supply 

   2.4. Export 



Any restrictions or clarifying remarks (for all users):  Authorised Wholesale Distribution Operation
2.2. Holding
2.2.1. Ambient warehouse of 15-25 °C storage locations:
NT-A-1-1 → NT-A-1-9 NT-D-1-1 → NT-D-1-3
NT-A-2-1 → NT-A-2-9 NT-D-2-1 → NT-D-2-3
NT-A-3-1 → NT-A-3-8 NT-D-3-1 → NT-D-3-3
NT-B-1-1 → NT-B-1-3 NT-E-1-1 → NT-E-1-3
NT-B-2-1 → NT-B-2-3 NT-E-2-1 → NT-E-2-3
NT-B-3-1 → NT-B-3-3 NT-E-3-1 → NT-E-3-3
NT-C-1-1 → NT-C-1-6 NT-F-1-1 → NT-F-1-2
NT-C-2-1 → NT-C-2-6 NT-K-1-1 → NT-K-1-4
NT-C-3-1 → NT-C-3-6 NT-K-2-1 → NT-K-2-4
NT-K-4-1 → NT-K-4-4

Storage location of not applicable product:

NT-E-1-4/NMF → NT-E-1-6/NMF
NT-E-2-4/NMF → NT-E-2-6/NMF
NT-E-3-4/NMF → NT-E-3-6/NMF
 
Damaged medicine storage locations:

NT-A-3-9/NT-SELEJT

Additional provisions based on national requirements

Name(s) of responsible person(s) Number of Diplome
Dr. Körösi Gábor János 54/1999 (pharmacist)



*Art 5 of Directive 2001/83/EC or Art 83 of Regulation EC/726/2004

**Without prejudice to further authorisations as may be required according to national legislation













Union Format for a Wholesale Distribution Authorisation

HU-D-QPHA


Page 1





Loading, please wait